ESGO-ESHRE-ESGE Guidelines of fertility sparing treatment in endometrial cancer patients

The European Society of Gynaecological Oncology (ESGO) together with the European Society of Human Reproduction and Embryology (ESHRE) and the European Society for Gynaecological Endoscopy (ESGE) is developing clinically relevant and evidence-based guidelines focusing on key aspects of fertility-sparing treatment in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwilde (patients selection, tumour clinicopathological characteristics, treatment, special issues).

The multidisciplinary international group consists of expert practising clinicians, researchers in the fields of gynecological oncology, human reproduction, endoscopy, and histopathology.

The development group is chaired by Prof. Alexandros Rodolakis (ESGO, Greece), Dr. Kirsten Louise Tryde Macklon (ESHRE, Denmark) and Prof. Giovanni Scambia (ESGE, Italy).

The article publication is expected in 2022.